We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+10.12%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.03B
AUM Growth
+$258M
Cap. Flow
+$193M
Cap. Flow %
9.48%
Top 10 Hldgs %
34.65%
Holding
2,402
New
679
Increased
420
Reduced
419
Closed
794

Sector Composition

Rank Sector Weight
1 Healthcare 7.64%
2 Technology 6.61%
3 Industrials 5.39%
4 Communication Services 5.27%
5 Consumer Discretionary 4.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTI icon
401
TechnipFMC
FTI
$27.3B
$795K 0.04%
+41,187
New +$722K
UNVR
402
DELISTED
Univar Solutions Inc.
UNVR
$792K 0.04%
35,950
+14,181
+65% +$310K
AMRN
403
CALL
Amarin Corp
AMRN
$301M
$791K 0.04%
+2,040
New +$747K
SFIX
404
Stitch Fix
SFIX
$538M
$785K 0.04%
24,537
+6,274
+34% +$168K
GE icon
405
GE Aerospace
GE
$389B
$783K 0.04%
14,971
-482
-3% -$23.7K
GRUB
406
CALL
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$780K 0.04%
5,000
-750
-13% -$102K
EQH icon
407
Equitable Holdings
EQH
$14.2B
$776K 0.04%
37,113
+14,827
+67% +$319K
JPST icon
408
JPMorgan Ultra-Short Income ETF
JPST
$40.3B
$773K 0.04%
+15,342
New +$773K
MRO
409
DELISTED
Marathon Oil Corporation
MRO
$769K 0.04%
+54,142
New +$837K
RRGB icon
410
CALL
Red Robin
RRGB
$156M
$764K 0.04%
+25,000
New +$767K
TAL icon
411
PUT
TAL Education Group
TAL
$6.91B
$762K 0.04%
20,000
-75,000
-79% -$2.71M
PCRX icon
412
Pacira BioSciences
PCRX
$1.02B
$754K 0.04%
17,327
+17,121
+8,311% +$727K
OXY icon
413
PUT
Occidental Petroleum
OXY
$55.7B
$744K 0.04%
+14,800
New +$833K
JPC icon
414
Nuveen Preferred & Income Opportunities Fund
JPC
$2.9B
$743K 0.04%
75,000
-50,000
-40% -$482K
MPWR icon
415
Monolithic Power Systems
MPWR
$66.8B
$740K 0.04%
5,449
+543
+11% +$73.9K
BHVN
416
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$739K 0.04%
16,869
+8,266
+96% +$466K
LRCX icon
417
PUT
Lam Research
LRCX
$383B
$733K 0.04%
39,000
-62,000
-61% -$1.18M
IQ icon
418
iQIYI
IQ
$1.24B
$729K 0.04%
+35,307
New +$730K
LNC icon
419
Lincoln National
LNC
$8.93B
$728K 0.04%
11,294
+2,690
+31% +$172K
WBA
420
CALL
DELISTED
Walgreens Boots Alliance
WBA
$727K 0.04%
13,300
+12,000
+923% +$638K
ONCE
421
PUT
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$727K 0.04%
+7,100
New +$766K
PCAR icon
422
PUT
PACCAR
PCAR
$69.5B
$717K 0.04%
+15,000
New +$697K
DBX icon
423
Dropbox
DBX
$8.06B
$710K 0.03%
+28,333
New +$655K
ODP
424
DELISTED
ODP
ODP
$700K 0.03%
+34,000
New +$770K
NESR
425
National Energy Services Reunited Corp
NESR
$2.91B
$695K 0.03%
+79,881
New +$762K

Similar funds

Prelude Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Prelude Capital Management held 2,402 positions worth $2.03B, up 15% from $1.77B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Prelude Capital Management deployed $193M of net new capital in Q2 2019, opening 679 new positions and adding to 420 existing holdings. Its largest new stake was Anadarko Petroleum: 593,600 shares worth $41.9M.

By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 6.7% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Red Hat Inc, an estimated $8.6M trimmed.

  • Prelude Capital Management's largest Q2 2019 buy was Anadarko Petroleum: 593,600 shares worth $41.9M.
  • Prelude Capital Management added most to Allergan plc in Q2 2019, an estimated $27.2M increase.
  • Prelude Capital Management's biggest Q2 2019 reduction was Red Hat Inc, cutting an estimated $8.6M.
  • Prelude Capital Management fully exited Travelport Worldwide Limited in Q2 2019, selling an estimated $27.8M.
  • Prelude Capital Management's ten largest holdings make up 35% of its $2.03B portfolio in Q2 2019.
  • Prelude Capital Management opened 679 new positions and closed 794 in Q2 2019.
  • Prelude Capital Management's portfolio value rose 15% quarter-over-quarter to $2.03B.

Based on Prelude Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.